https://www.selleckchem.com/pr....oducts/isoxazole-9-i
4% versus 95.3%, adjusted OR for PF 2.79 (CI 95% 1.93-4.04), 0.001) and 41 min in CTO PCI (procedural success in 92.3% versus 83.8%, adjusted OR for PF 2.18 (CI 95% 1.64-2.94), 0.001). In CTO PCI, the increase in PF with FT was largely driven by technical failure (adjusted OR 2.25 (CI 95% 1.65-3.1, 0.001), whereas in non-CTO PCI, it was driven by major complications (adjusted OR 2.94 (CI 95% 1.93-4.53), 0.001). Prolonged FT is strongly associated with procedural failure in both non-CTO and CTO PCI. In CTO
Like
Comment
Share
